Axsome Therapeutics (AXSM) Cash from Operations Growth (3y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 37.40% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 20.11% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 16.64% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -7.60% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 34.32% |
| 10 | Axsome Therapeutics | 11.82 Bn | 11.51 Bn | 176.48 Mn | -52.64% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -52.64% |
| Dec 31, 2025 | 12.20% |
| Sep 30, 2025 | 26.95% |
| Jun 30, 2025 | 1.12% |
| Mar 31, 2025 | -9.93% |
| Dec 31, 2024 | 3.15% |
| Sep 30, 2024 | 11.39% |
| Jun 30, 2024 | -5.84% |
| Mar 31, 2024 | -25.24% |
| Dec 31, 2023 | -13.89% |
| Sep 30, 2023 | -50.42% |
| Jun 30, 2023 | -43.08% |
| Mar 31, 2023 | 36.99% |
| Dec 31, 2022 | -16.20% |
| Sep 30, 2022 | -28.90% |
| Jun 30, 2022 | -56.91% |
| Mar 31, 2022 | -50.92% |
| Dec 31, 2021 | -43.33% |
| Sep 30, 2021 | -65.45% |
| Jun 30, 2021 | -49.06% |
| Mar 31, 2021 | -59.71% |
| Dec 31, 2020 | -48.38% |
| Sep 30, 2020 | -34.63% |
| Jun 30, 2020 | -38.60% |
| Mar 31, 2020 | -51.93% |
| Dec 31, 2019 | -34.52% |
| Sep 30, 2019 | -30.31% |
| Jun 30, 2019 | -17.77% |
| Mar 31, 2019 | -34.00% |
| Dec 31, 2018 | -63.26% |
| Sep 30, 2018 | -45.42% |
| Jun 30, 2018 | -53.82% |
| Mar 31, 2018 | -79.31% |